SignalXSignalX

VRDN Viridian Therapeutics, Inc.\DE

8-K Current Report
Filed: February 26, 2026
Health Care
Pharmaceutical Preparations
Viridian Therapeutics, Inc.\DE Overview

Viridian Therapeutics, Inc.\DE (VRDN) 8-K current report filed with SEC EDGAR on February 26, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

  • Item 2.02: Results of Operations and Financial Condition

AI Filing Analysis
8-K

Item 2.02 · Results of Operations and Financial Condition

  • • Q1 2025 earnings press release furnished as exhibit — refer to Exhibit 99.1 for key financial figures
  • • Filed under Item 2.02; not subject to Section 18 liability, meaning not formally "filed" with SEC

Get deeper insights on Viridian Therapeutics, Inc.\DE

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.